Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

First described in 2009 in Japan, the emerging multidrug-resistant fungal pathogen Candida
auris is becoming a worldwide public health threat that has been attracting considerable …

Chronic wounds are often recalcitrant to treatment because of high microbial bioburden and
the problem of microbial resistance. Silver is a broad-spectrum natural antimicrobial agent …

The landscape of clinical mycology is constantly changing. New therapies for malignant and
autoimmune diseases have led to new risk factors for unusual mycoses. Invasive …

Candida spp. infections are a major cause of morbidity and mortality in critically ill patients.
Candida auris is an emerging multi-drug-resistant fungus that is rapidly spreading …

Candida auris is an invasive fungal pathogen that has been recognized globally as a
serious health threat due to its extensive innate and acquired resistance to antifungal drugs …

summary A paradigm shift of candidiasis from Candida albicans to non‐albicans Candida
species has fundamentally increased with the advent of C. auris. C. auris, despite being a …

Candida auris is an emerging multi-drug resistant yeast, that causes major issues regarding
patient treatment and surface disinfection in hospitals. Indeed, an important proportion of C …

Background Candida auris is a new pathogen called “superbug fungus” which caused panic
worldwide. There are no large-scale epidemiology studies by now, therefore a systematic …

Candida auris is an emerging multidrug-resistant fungus that is rapidly spreading worldwide.
Currently, C. auris cases have been reported globally from> 30 countries. Most reported …